Exact Mass: 443.26715920000004
Exact Mass Matches: 443.26715920000004
Found 187 metabolites which its exact mass value is equals to given mass value 443.26715920000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Docosahexaenoyl Aspartic acid
C26H37NO5 (443.26715920000004)
N-docosahexaenoyl aspartic acid belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Aspartic acid is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Ala Ile Ile Gln
Ala Ile Leu Gln
Ala Ile Gln Ile
Ala Ile Gln Leu
Ala Leu Ile Gln
Ala Leu Leu Gln
Ala Leu Gln Ile
Ala Leu Gln Leu
Ala Gln Ile Ile
Ala Gln Ile Leu
Ala Gln Leu Ile
Ala Gln Leu Leu
Ile Ala Ile Gln
Ile Ala Leu Gln
Ile Ala Gln Ile
Ile Ala Gln Leu
Ile Ile Ala Gln
Ile Ile Gln Ala
Ile Lys Pro Ser
Ile Lys Ser Pro
Ile Leu Ala Gln
Ile Leu Gln Ala
Ile Asn Val Val
Ile Pro Lys Ser
Ile Pro Ser Lys
Ile Gln Ala Ile
Ile Gln Ala Leu
Ile Gln Ile Ala
Ile Gln Leu Ala
Ile Ser Lys Pro
Ile Ser Pro Lys
Ile Val Asn Val
Ile Val Val Asn
Lys Ile Pro Ser
Lys Ile Ser Pro
Lys Leu Pro Ser
Lys Leu Ser Pro
Lys Pro Ile Ser
Lys Pro Leu Ser
Lys Pro Ser Ile
Lys Pro Ser Leu
Lys Pro Thr Val
Lys Pro Val Thr
Lys Ser Ile Pro
Lys Ser Leu Pro
Lys Ser Pro Ile
Lys Ser Pro Leu
Lys Thr Pro Val
Lys Thr Val Pro
Lys Val Pro Thr
Lys Val Thr Pro
Leu Ala Ile Gln
Leu Ala Leu Gln
Leu Ala Gln Ile
Leu Ala Gln Leu
Leu Ile Ala Gln
Leu Ile Gln Ala
Leu Lys Pro Ser
Leu Lys Ser Pro
Leu Leu Ala Gln
Leu Leu Gln Ala
Leu Asn Val Val
Leu Pro Lys Ser
Leu Pro Ser Lys
Leu Gln Ala Ile
Leu Gln Ala Leu
Leu Gln Ile Ala
Leu Gln Leu Ala
Leu Ser Lys Pro
Leu Ser Pro Lys
Leu Val Asn Val
Leu Val Val Asn
Asn Ile Val Val
Asn Leu Val Val
Asn Val Ile Val
Asn Val Leu Val
Asn Val Val Ile
Asn Val Val Leu
Pro Ile Lys Ser
Pro Ile Ser Lys
Pro Lys Ile Ser
Pro Lys Leu Ser
Pro Lys Ser Ile
Pro Lys Ser Leu
Pro Lys Thr Val
Pro Lys Val Thr
Pro Leu Lys Ser
Pro Leu Ser Lys
Pro Ser Ile Lys
Pro Ser Lys Ile
Pro Ser Lys Leu
Pro Ser Leu Lys
Pro Thr Lys Val
Pro Thr Val Lys
Pro Val Lys Thr
Pro Val Thr Lys
Gln Ala Ile Ile
Gln Ala Ile Leu
Gln Ala Leu Ile
Gln Ala Leu Leu
Gln Ile Ala Ile
Gln Ile Ala Leu
Gln Ile Ile Ala
Gln Ile Leu Ala
Gln Leu Ala Ile
Gln Leu Ala Leu
Gln Leu Ile Ala
Gln Leu Leu Ala
Gln Val Val Val
Ser Ile Lys Pro
Ser Ile Pro Lys
Ser Lys Ile Pro
Ser Lys Leu Pro
Ser Lys Pro Ile
Ser Lys Pro Leu
Ser Leu Lys Pro
Ser Leu Pro Lys
Ser Pro Ile Lys
Ser Pro Lys Ile
Ser Pro Lys Leu
Ser Pro Leu Lys
Thr Lys Pro Val
Thr Lys Val Pro
Thr Pro Lys Val
Thr Pro Val Lys
Thr Val Lys Pro
Thr Val Pro Lys
Val Ile Asn Val
Val Ile Val Asn
Val Lys Pro Thr
Val Lys Thr Pro
Val Leu Asn Val
Val Leu Val Asn
Val Asn Ile Val
Val Asn Leu Val
Val Asn Val Ile
Val Asn Val Leu
Val Pro Lys Thr
Val Pro Thr Lys
Val Gln Val Val
Val Thr Lys Pro
Val Thr Pro Lys
Val Val Ile Asn
Val Val Leu Asn
Val Val Asn Ile
Val Val Asn Leu
Val Val Gln Val
Val Val Val Gln
cyclopropyl methyl amide
C26H37NO5 (443.26715920000004)
Bis[(4S)-4-(4-tert-butylphenyl)-4,5-dihydro-2-oxazolyl]acetonitrile
C28H33N3O2 (443.25726380000003)
N-(cyclopropylmethyl)-7-[3,5-dihydroxy-2-(3-hydroxy-4-phenoxybut-1-enyl)cyclopentyl]hept-5-enamide
C26H37NO5 (443.26715920000004)
4-ethyl-N-[2-methyl-5-[[4-(3-methylbutyl)piperazin-1-yl]methyl]phenyl]benzenesulfonamide
2-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid
C26H37NO5 (443.26715920000004)
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyl-24-oxotetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenoate
4-[[[(2S,3R,5aS,10aS)-3-(4-hydroxyphenyl)-5,10-dioxo-1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1,3-f]pyrazin-2-yl]-oxomethyl]amino]butyl-trimethylammonium
[(8S,9S,10R)-6-[(3-methoxyphenyl)methyl]-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C28H33N3O2 (443.25726380000003)
[(8S,9R,10R)-6-[(3-methoxyphenyl)methyl]-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C28H33N3O2 (443.25726380000003)
[(8S,9S,10S)-6-[(3-methoxyphenyl)methyl]-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C28H33N3O2 (443.25726380000003)
NA-Asp 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C26H37NO5 (443.26715920000004)
(2e,4e,6e,8r,10r)-1-[5-(1,4-dihydroxycyclohexyl)-2,4-dihydroxypyridin-3-yl]-6,8,10-trimethyldodeca-2,4,6-trien-1-one
C26H37NO5 (443.26715920000004)
(3s,3as,6s,7s,7as)-3-benzyl-7-[(1e,4s,5s,6s)-5,6-dihydroxy-4-methylhept-1-en-1-yl]-6-methoxy-4,5-dimethyl-3,3a,6,7-tetrahydroisoindole-1,7a-diol
C26H37NO5 (443.26715920000004)
(3s,6e,8r,9s,10z,12s,13r,14r,15s)-3-benzyl-9,13-dihydroxy-4,8,10,12,14,15-hexamethyl-1-oxa-4-azacyclopentadeca-6,10-diene-2,5-dione
C26H37NO5 (443.26715920000004)
3-benzyl-9,13-dihydroxy-4,8,10,12,14,15-hexamethyl-1-oxa-4-azacyclopentadeca-6,10-diene-2,5-dione
C26H37NO5 (443.26715920000004)
(2e,4e,6e,8r,10r)-1-{2,4-dihydroxy-5-[(1s,4s)-1,4-dihydroxycyclohexyl]pyridin-3-yl}-6,8,10-trimethyldodeca-2,4,6-trien-1-one
C26H37NO5 (443.26715920000004)
2-[(5r,8r,10r,11r,12s,14s,16r,17r)-12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate
C26H37NO5 (443.26715920000004)
2-[(1r,5r,8r,10r,11r,12s,14s,16r,17r)-12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate
C26H37NO5 (443.26715920000004)
(1r,2r,4s,5s,7r,8r,13r,16r,17r)-4-(acetyloxy)-11-ethyl-16-hydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-yl acetate
C26H37NO5 (443.26715920000004)
2-[12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate
C26H37NO5 (443.26715920000004)
(1r,2s,4s,7r,8s,9s,10s,11r,12r)-8-(acetyloxy)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-9-yl acetate
C26H37NO5 (443.26715920000004)
(1r,2s,4s,7r,8s,9s,10s,11r,12s)-8-(acetyloxy)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-9-yl acetate
C26H37NO5 (443.26715920000004)
(2e,4e,6e,8r,10r)-1-{2,4-dihydroxy-5-[(1r,4r)-1,4-dihydroxycyclohexyl]pyridin-3-yl}-6,8,10-trimethyldodeca-2,4,6-trien-1-one
C26H37NO5 (443.26715920000004)
1-[5-(1,4-dihydroxycyclohexyl)-2,4-dihydroxypyridin-3-yl]-6,8,10-trimethyldodeca-2,4,6-trien-1-one
C26H37NO5 (443.26715920000004)